LIPATIMZIMA
Live / Registered — Registered (as of 08 Jun 2021)
What this means for you
Registered since 08 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79296576
- Registration number
- 6375329
- Mark type
- Stylized text
- Filed
- 03 Sept 2020
- Published for opposition
- 23 Mar 2021
- Registered
- 08 Jun 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 25 Oct 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Sept 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 29 Sept 2021 — FINAL DISPOSITION PROCESSED
- 08 Sept 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION
- 22 Mar 2021 — NOTIFICATION PROCESSED BY IB
- 03 Mar 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Mar 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 03 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jan 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jan 2021 — REFUSAL PROCESSED BY IB